SJS Investment Consulting’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
Other funds holding RNAM
SJS Investment Consulting's RNAM Position: Q1 2026 in Review
SJS Investment Consulting sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 1 share — an estimated $73 sold.
SJS Investment Consulting first reported a position in RNAM in Q3 2025 and held it in 2 quarters. The position peaked at $73 in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- SJS Investment Consulting reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- SJS Investment Consulting sold 1 Avidity Biosciences share in Q1 2026, an estimated $73.
- SJS Investment Consulting first reported a position in Avidity Biosciences in Q3 2025 and held it in 2 quarters.
- SJS Investment Consulting's Avidity Biosciences position peaked at $73 in Q4 2025.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on SJS Investment Consulting's 13F filing for Q1 2026, filed 23 Apr 2026.